A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/185 (2006.01) A61P 9/00 (2006.01) A61P 13/12 (2006.01)
Patent
CA 2582611
A method of treating elevated plasma total homocysteine levels (tHc) in subjects with end stage renal disease (ESRD) is disclosed, said treatment comprising the administration of sodium 2-mercaptoethylsulfonate (MESNA) immediately prior to, or concurrently with, performing hemodialysis on said patient.
L'invention porte sur un procédé qui permet de traiter les niveaux plasmiques totaux élevés d'homocystéine chez des sujets souffrant d'insuffisance rénale chronique au stade ultime (IRSU), selon lequel on administre au sujet qui en a besoin une quantité efficace de mesna ou d'un dérivé de ce dernier.
Freeman David J.
House Andrew A.
Spence J. David
Urquhart Bradley L.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
London Health Sciences Centre Research Inc.
LandOfFree
Method of treating elevated plasma homocysteine levels in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating elevated plasma homocysteine levels in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating elevated plasma homocysteine levels in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1825567